THE PENNANT GROUP, INC. Income Tax Expense
THE PENNANT GROUP, INC. (PNTG) reported Income Tax Expense of $3.94 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-05
- THE PENNANT GROUP, INC. income tax expense (benefit) for the quarter ending 2026-06-30 was $3.94M, a 51.50% increase year-over-year.
- THE PENNANT GROUP, INC. income tax expense (benefit) for the quarter ending 2026-03-31 was $3.79M, a 32.94% increase year-over-year.
- THE PENNANT GROUP, INC. income tax expense (benefit) for the quarter ending 2025-12-31 was $3.90M, a 88.12% increase year-over-year.
- THE PENNANT GROUP, INC. income tax expense (benefit) for the quarter ending 2025-09-30 was $2.52M, a 85.97% increase year-over-year.
- THE PENNANT GROUP, INC. income tax expense (benefit) for fiscal 2025 was $11.87M, a 68.84% increase from fiscal 2024.
- THE PENNANT GROUP, INC. income tax expense (benefit) for fiscal 2024 was $7.03M, a 23.86% increase from fiscal 2023.
- THE PENNANT GROUP, INC. income tax expense (benefit) for fiscal 2023 was $5.67M, a 244.09% increase from fiscal 2022.
- THE PENNANT GROUP, INC. income tax expense (benefit) for fiscal 2022 was $1.65M, a 183.33% increase from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.94M 10-Q · filed 2026-08-05 | $7.73M 10-Q · filed 2026-08-05 | $11.63M derived: sum of 3 quarters · filed 2026-08-05 | $14.14M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $3.79M 10-Q · filed 2026-05-06 | $7.69M derived: sum of 2 quarters · filed 2026-05-06 | $10.21M derived: sum of 3 quarters · filed 2026-05-06 | $12.81M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.41M derived: sum of 2 quarters · filed 2026-02-26 | $9.01M derived: sum of 3 quarters · filed 2026-08-05 | $11.87M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.52M 10-Q · filed 2025-11-05 | $5.12M derived: sum of 2 quarters · filed 2026-08-05 | $7.97M 10-Q · filed 2025-11-05 | $10.04M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $2.60M 10-Q · filed 2026-08-05 | $5.45M 10-Q · filed 2026-08-05 | $7.52M derived: sum of 3 quarters · filed 2026-08-05 | $8.88M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $2.85M 10-Q · filed 2026-05-06 | $4.92M derived: sum of 2 quarters · filed 2026-05-06 | $6.28M derived: sum of 3 quarters · filed 2026-05-06 | $8.12M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.42M derived: sum of 2 quarters · filed 2026-02-26 | $5.27M derived: sum of 3 quarters · filed 2026-02-26 | $7.03M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.35M 10-Q · filed 2025-11-05 | $3.20M derived: sum of 2 quarters · filed 2025-11-05 | $4.96M 10-Q · filed 2025-11-05 | $6.74M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $1.84M 10-Q · filed 2025-08-06 | $3.60M 10-Q · filed 2025-08-06 | $5.38M derived: sum of 3 quarters · filed 2026-02-26 | $6.45M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $1.76M 10-Q · filed 2025-05-06 | $3.54M derived: sum of 2 quarters · filed 2026-02-26 | $4.61M derived: sum of 3 quarters · filed 2026-02-26 | $6.53M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.85M derived: sum of 2 quarters · filed 2026-02-26 | $4.77M derived: sum of 3 quarters · filed 2026-02-26 | $5.67M 10-K · filed 2026-02-26 |
| 2023-09-30 | $1.07M 10-Q · filed 2024-11-06 | $2.99M derived: sum of 2 quarters · filed 2024-11-06 | $3.89M 10-Q · filed 2024-11-06 | $5.30M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $1.92M 10-Q · filed 2024-08-06 | $2.83M 10-Q · filed 2024-08-06 | $4.24M derived: sum of 3 quarters · filed 2025-02-27 | $5.31M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $907.00K 10-Q · filed 2024-05-06 | $2.31M derived: sum of 2 quarters · filed 2025-02-27 | $3.39M derived: sum of 3 quarters · filed 2025-02-27 | $2.01M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.48M derived: sum of 2 quarters · filed 2025-02-27 | $1.11M derived: sum of 3 quarters · filed 2025-02-27 | $1.65M 10-K · filed 2025-02-27 |
| 2022-09-30 | $1.07M 10-Q · filed 2023-11-07 | -$301.00K derived: sum of 2 quarters · filed 2023-11-07 | $241.00K 10-Q · filed 2023-11-07 | -$190.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$1.38M 10-Q · filed 2023-08-08 | -$833.00K 10-Q · filed 2023-08-08 | -$1.26M derived: sum of 3 quarters · filed 2024-02-28 | -$1.20M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $542.00K 10-Q · filed 2023-05-04 | $111.00K derived: sum of 2 quarters · filed 2024-02-28 | $180.00K derived: sum of 3 quarters · filed 2024-02-28 | $784.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$431.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$362.00K derived: sum of 2 quarters · filed 2024-02-28 | $242.00K derived: sum of 3 quarters · filed 2024-02-28 | $582.00K 10-K · filed 2024-02-28 |
| 2021-09-30 | $69.00K 10-Q · filed 2022-11-07 | $673.00K derived: sum of 2 quarters · filed 2022-11-07 | $1.01M 10-Q · filed 2022-11-07 | $933.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $604.00K 10-Q · filed 2022-08-08 | $944.00K 10-Q · filed 2022-08-08 | $864.00K derived: sum of 3 quarters · filed 2023-02-23 | $968.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $340.00K 10-Q · filed 2022-05-09 | $260.00K derived: sum of 2 quarters · filed 2023-02-23 | $364.00K derived: sum of 3 quarters · filed 2023-02-23 | $1.80M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | -$80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $24.00K derived: sum of 2 quarters · filed 2023-02-23 | $1.46M derived: sum of 3 quarters · filed 2023-02-23 | $2.35M 10-K · filed 2023-02-23 |
| 2020-09-30 | $104.00K 10-Q · filed 2021-11-08 | $1.54M derived: sum of 2 quarters · filed 2021-11-08 | $2.43M 10-Q · filed 2021-11-08 | $4.42M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $1.44M 10-Q · filed 2021-08-09 | $2.33M 10-Q · filed 2021-08-09 | $4.32M derived: sum of 3 quarters · filed 2022-02-28 | $4.44M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $889.00K 10-Q · filed 2021-05-06 | $2.88M derived: sum of 2 quarters · filed 2022-02-28 | $3.01M derived: sum of 3 quarters · filed 2022-02-28 | $2.63M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $2.12M derived: sum of 2 quarters · filed 2022-02-28 | $1.74M derived: sum of 3 quarters · filed 2022-02-28 | $2.08M 10-K · filed 2022-02-28 |
| 2019-09-30 | $123.00K 10-Q · filed 2020-11-10 | -$252.00K derived: sum of 2 quarters · filed 2020-11-10 | $91.00K 10-Q · filed 2020-11-10 | $855.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | -$375.00K 10-Q · filed 2020-08-11 | -$32.00K 10-Q · filed 2020-08-11 | $732.00K derived: sum of 3 quarters · filed 2021-02-24 | $2.12M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $343.00K 10-Q · filed 2020-05-13 | $1.11M derived: sum of 2 quarters · filed 2021-02-24 | $2.50M derived: sum of 3 quarters · filed 2021-02-24 | |
| 2018-12-31 | $764.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $2.15M derived: sum of 2 quarters · filed 2021-02-24 | $4.35M 10-K · filed 2021-02-24 | |
| 2018-09-30 | $1.39M 10-Q · filed 2019-11-12 | $3.59M 10-Q · filed 2019-11-12 | ||
| 2017-12-31 | $5.38M 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |